Synthesis and biological evaluation of a polyglutamic acid-dopamine conjugate: A new antiangiogenic agent

Journal of Medicinal Chemistry

Volumn 54, Issue 14, 2011, Pages 5255-5259

  Fante, Cristina ^a   Eldar Boock, Anat ^b   Satchi Fainaro, Ronit ^b   Osborn, Helen M I ^a   Greco, Francesca ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; DOPAMINE; DOPAMINE POLYGLUTAMIC ACID CONJUGATE; MONOMER; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CARBON NUCLEAR MAGNETIC RESONANCE; CELL MIGRATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG HALF LIFE; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INHIBITORS; ANIMALS; CAPILLARY PERMEABILITY; CELL MOVEMENT; DOPAMINE; ENDOTHELIAL CELLS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; POLYGLUTAMIC ACID; STRUCTURE-ACTIVITY RELATIONSHIP; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960625073     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm200382r     Document Type: Article

References (24)

1. Carmeliet, P. Angiogenesis in health and disease Nat. Med. 2003, 9, 653-660 (Pubitemid 36749213)
2. Folkman, J. Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discovery 2007, 6, 273-286 (Pubitemid 46505878)
3. Naumov, G. N.; Akslen, L. A.; Folkman, J. Role of angiogenesis in human tumor dormancy. Animal models of the angiogenic switch Cell Cycle 2006, 5, 1779-1787 (Pubitemid 44435320)
4. Hurwitz, H.; Fehrenbacher, L.; Novotny, W.; Cartwright, T.; Hainsworth, J.; Heim, W.; Berlin, J.; Baron, A.; Griffing, S.; Holmgren, E.; Ferrara, N.; Fyfe, G.; Rogers, B.; Ross, R.; Kabbinavar, F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N. Engl. J. Med. 2004, 350, 2335-2342 (Pubitemid 38702844)
5. Kamba, T.; Mc Donald, D. M. Mechanisms of adverse effects of anti-VEGF therapy for cancer Br. J. Cancer 2007, 96, 1788-1795 (Pubitemid 46912024)
6. Flagel, S. B.; Clark, J. J.; Robinson, T. E.; Mayo, L.; Czuj, A.; Willuhn, I.; Akers, C. A.; Clinton, S. M.; Phillips, P. E. M.; Akil, H. A selective role for dopamine in stimulus-reward learning Nature 2010, 469, 53-57
7. Karabanova, A.; Cervenkac, S.; de Manzanoa, O.; Forssberga, H.; Fardec, L.; Ullén, F. Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 7574-7579
8. Basu, S.; Nagy, J. A.; Pal, S.; Vasile, E.; Eckelhoefer, I. A.; Bliss, V. S.; Manseau, E. J.; Dasgupta, P. S.; Dvorak, H. F.; Mukhopadhyay, D. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor Nat. Med. 2001, 7, 569-573
9. Sarkar, C.; Chakroborty, D.; Basu Mitra, R.; Banerjee, S.; Dasgupta, P. S.; Basu, S. Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR2, MAPK, and focal adhesion kinase in endothelial cells Am. J. Physiol.: Heart Circ. Physiol. 2004, 287, 1554-1560
10. MacGregor, D. A.; Smith, T. E.; Prielipp, R. C.; Butterworth, J. F.; James, R. L.; Scuderi, P. E. Pharmacokinetics of dopamine in healthy male subjects Anesthesiology 2000, 92, 338-346 (Pubitemid 30078329)
11. Kisker, O.; Becker, C. M.; Prox, D.; Fannon, M.; D'Amato, R.; Flynn, E.; Fogler, W. E.; Sim, B. K. L.; Allred, E. N.; Pirie-Shepherd, S. R.; Folkman, J. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model Cancer Res. 2001, 61, 7669-7674 (Pubitemid 32995064)
12. Boddy, A. V.; Plummer, R.; Todd, R.; Sludden, J.; Griffin, M.; Robson, L.; Cassidy, J.; Bissett, D.; Bernareggi, A; Verrill, M. W.; Calvert, A. H. A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules Clin. Cancer Res. 2005, 11, 7834-7840 (Pubitemid 41611628)
13. Duncan, R. Polymer conjugates as anticancer nanomedicines Nat. Rev. Cancer 2006, 6, 688-701 (Pubitemid 44286001)
14. Paz-Ares, L.; Ross, H.; O'Brien, M.; Riviere, A.; Gatzemeier, U.; Von Pawel, J.; Kaukel, J.; Freitag, L.; Digel, L.; Bischoff, H.; Garcia-Campelo, R.; Iannotti, N.; Reiterer, P.; Bover, I.; Prendiville, J.; Eisenfeld, A. L.; Oldham, F. B.; Bandstra, B.; Singer, J. W.; Bonomi, P. Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer Br. J. Cancer 2008, 98, 1608-1613 (Pubitemid 351684693)
15. Satchi-Fainaro, R.; Puder, M.; Davies, J. W.; Tran, H. T.; Sampson, D. A.; Greene, A. K.; Corfas, G.; Folkman, J. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470 Nat. Med. 2004, 10, 255-261 (Pubitemid 38667615)
16. Liang, C. C.; Park, A. Y.; Guan, J. L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro Nat. Protoc. 2007, 2, 329-333 (Pubitemid 47040047)
17. Miles, A. A.; Miles, E. M. Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs J. Physiol. 1952, 118, 228-257
18. Gerhardt, H.; Golding, M.; Fruttiger, M.; Ruhrberg, C.; Lundkvist, A.; Abramsson, A.; Jeltsch, M.; Mitchell, C.; Alitalo, K.; Shima, D.; Betsholtz, C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia J. Cell Biol. 2003, 161, 1163-1177 (Pubitemid 36870177)
19. Satchi-Fainaro, R.; Mamluk, R.; Wang, l.; Short, S. M.; Nagy, J. A.; Feng, D.; Dvorak, A. M.; Dvorak, H. F.; Puder, M.; Mukhopadhyay, D.; Folkman, J. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin Cancer Cell 2005, 7, 251-261 (Pubitemid 40568684)
20. Bisaglia, M.; Mammi, S.; Bubacco, L. Kinetic and structural analysis of the early oxidation products of dopamine J. Biol. Chem. 2007, 282, 15597-15605
21. Singer, J. W.; Bhatt, R.; Tulinsky, J.; Buhler, K. R.; Heasley, E.; Klein, P.; de Vries, P. Water-soluble poly-(l -glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo J. Controlled Release 2001, 74, 243-247 (Pubitemid 32727627)
22. Kamba, T.; Tam, B. Y. Y.; Hashizume, H.; Haskell, A.; Sennino, B.; Mancuso, M. R.; Norberg, S. M.; O'Brien, S. M.; Davis, R. B.; Gowen, L. C.; Anderson, K. D.; Thurston, G.; Joho, S.; Springer, M. L.; Kuo, C. J.; McDonald, D. M. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature Am. J. Physiol.: Heart. Circ. Physiol. 2006, 290, 560-576
23. De Backer, D.; Biston, P.; Devriendt, J.; Madl, C.; Chochrad, D.; Aldecoa, C.; Brasseur, A.; Defrance, P.; Gottignies, P.; Vincent, J. L. Comparison of dopamine and norepinephrine in the treatment of shock N. Engl. J. Med. 2010, 362, 779
24. Greco, F.; Vicent, J. M. Polymer-drug conjugates: current status and future trends Front. Biosci. 2008, 13, 2744-2756 (Pubitemid 351611606)